To hear about similar clinical trials, please enter your email below

Trial Title: Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer

NCT ID: NCT05684549

Condition: Surgery
Corona Virus Infection

Conditions: Official terms:
Infections
Communicable Diseases
Coronavirus Infections
Virus Diseases
Lung Neoplasms

Conditions: Keywords:
Lung cancer
Surgery
Corona Virus Infection

Study type: Observational

Overall status: Active, not recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Other
Intervention name: No intervention
Description: Observational study, no intervention
Arm group label: stage I/II lung cancer patients

Summary: The goal of this observational study is to learn about the effects of coronavirus infection in patients with early-stage lung cancer. The main question it aims to answer is whether the interval of surgery and COVID-19 infection will affect the surgery and prognosis of the patients.

Criteria for eligibility:

Study pop:
Patients with clinically diagnosed stage I or stage II lung cancer who are about to receive radical surgery.

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Clinically diagnosed stage I and stage II lung cancer, who are about to receive wedge resection, segmental resection, sleeve resection, lobectomy, or pneumonectomy under general anaesthesia. - Volunteer to participate in the study with good compliance. Able to complete the observation and follow-up and have signed the informed consent. - ASA score: I-III; - Cardiopulmonary functions meet the requirements of radical operation for lung cancer with normal liver and kidney functions. Exclusion Criteria: - Neurologic, mental illness or mental disorder which is hard to control, poor compliance, unable to cooperate or describe the treatment response; - Clinically diagnosed stage III and stage IV lung cancer or patients who received neoadjuvant treatment before surgery; - Patients developed symptoms alike coronavirus infection but are not confirmed by viral RNA detection by quantitative RT-PCR or antigen testing kits. - Serious heart, lung, liver and kidney dysfunction and unable to tolerate the operation

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Address:
City: Shanghai
Zip: 200000
Country: China

Start date: January 11, 2023

Completion date: December 31, 2024

Lead sponsor:
Agency: Ruijin Hospital
Agency class: Other

Source: Ruijin Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05684549

Login to your account

Did you forget your password?